<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 39.96?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
    <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
    <journal-id journal-id-type="publisher-id">plos</journal-id>
    <journal-title-group>
      <journal-title>PLoS ONE</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1932-6203</issn>
    <publisher>
      <publisher-name>Public Library of Science</publisher-name>
      <publisher-loc>San Francisco, CA USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9292119</article-id>
    <article-id pub-id-type="doi">10.1371/journal.pone.0265368</article-id>
    <article-id pub-id-type="publisher-id">PONE-D-22-05647</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research Article</subject>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Epidemiology</subject>
          <subj-group>
            <subject>Medical Risk Factors</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Endocrinology</subject>
          <subj-group>
            <subject>Endocrine Disorders</subject>
            <subj-group>
              <subject>Diabetes Mellitus</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Metabolic Disorders</subject>
            <subj-group>
              <subject>Diabetes Mellitus</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Cardiovascular Diseases</subject>
            <subj-group>
              <subject>Cardiovascular Disease Risk</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Cardiology</subject>
          <subj-group>
            <subject>Cardiovascular Medicine</subject>
            <subj-group>
              <subject>Cardiovascular Diseases</subject>
              <subj-group>
                <subject>Cardiovascular Disease Risk</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Epidemiology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Medical Conditions</subject>
          <subj-group>
            <subject>Cardiovascular Diseases</subject>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Cardiology</subject>
          <subj-group>
            <subject>Cardiovascular Medicine</subject>
            <subj-group>
              <subject>Cardiovascular Diseases</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Medicine and Health Sciences</subject>
        <subj-group>
          <subject>Public and Occupational Health</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Probability Theory</subject>
            <subj-group>
              <subject>Probability Distribution</subject>
              <subj-group>
                <subject>Normal Distribution</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Research and Analysis Methods</subject>
        <subj-group>
          <subject>Mathematical and Statistical Techniques</subject>
          <subj-group>
            <subject>Statistical Methods</subject>
            <subj-group>
              <subject>Generalized Linear Model</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="Discipline-v3">
        <subject>Physical Sciences</subject>
        <subj-group>
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Statistics</subject>
            <subj-group>
              <subject>Statistical Methods</subject>
              <subj-group>
                <subject>Generalized Linear Model</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Introducing riskCommunicator: An R package to obtain interpretable effect estimates for public health</article-title>
      <alt-title alt-title-type="running-head">riskCommunicator R package for public health communication</alt-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6142-4913</contrib-id>
        <name>
          <surname>Grembi</surname>
          <given-names>Jessica A.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
        <role content-type="http://credit.niso.org/contributor-roles/validation/">Validation</role>
        <role content-type="http://credit.niso.org/contributor-roles/visualization/">Visualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff001" ref-type="aff">
          <sup>1</sup>
        </xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4942-3747</contrib-id>
        <name>
          <surname>Rogawski McQuade</surname>
          <given-names>Elizabeth T.</given-names>
        </name>
        <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
        <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
        <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
        <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
        <role content-type="http://credit.niso.org/contributor-roles/investigation/">Investigation</role>
        <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
        <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
        <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
        <xref rid="aff002" ref-type="aff">
          <sup>2</sup>
        </xref>
        <xref rid="cor001" ref-type="corresp">*</xref>
      </contrib>
    </contrib-group>
    <aff id="aff001">
      <label>1</label>
      <addr-line>Division of Infectious Diseases and Global Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States of America</addr-line>
    </aff>
    <aff id="aff002">
      <label>2</label>
      <addr-line>Department of Epidemiology, Emory University, Atlanta, GA, United States of America</addr-line>
    </aff>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Shen</surname>
          <given-names>Weining</given-names>
        </name>
        <role>Editor</role>
        <xref rid="edit1" ref-type="aff"/>
      </contrib>
    </contrib-group>
    <aff id="edit1">
      <addr-line>University of California Irvine, UNITED STATES</addr-line>
    </aff>
    <author-notes>
      <fn fn-type="COI-statement" id="coi001">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <corresp id="cor001">* E-mail: <email>erogaws@emory.edu</email></corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>18</day>
      <month>7</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>17</volume>
    <issue>7</issue>
    <elocation-id>e0265368</elocation-id>
    <history>
      <date date-type="received">
        <day>28</day>
        <month>2</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>6</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2022 Grembi, Rogawski McQuade</copyright-statement>
      <copyright-year>2022</copyright-year>
      <copyright-holder>Grembi, Rogawski McQuade</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
      </license>
    </permissions>
    <self-uri content-type="pdf" xlink:href="pone.0265368.pdf"/>
    <abstract>
      <p>Common statistical modeling methods do not necessarily produce the most relevant or interpretable effect estimates to communicate risk. Overreliance on the odds ratio and relative effect measures limit the potential impact of epidemiologic and public health research. We created a straightforward R package, called riskCommunicator, to facilitate the presentation of a variety of effect measures, including risk differences and ratios, number needed to treat, incidence rate differences and ratios, and mean differences. The riskCommunicator package uses g-computation with parametric regression models and bootstrapping for confidence intervals to estimate effect measures in time-fixed data. We demonstrate the utility of the package using data from the Framingham Heart Study to estimate the effect of prevalent diabetes on the 24-year risk of cardiovascular disease or death. The package promotes the communication of public-health relevant effects and is accessible to a broad range of epidemiologists and health researchers with little to no expertise in causal inference methods or advanced coding.</p>
    </abstract>
    <funding-group>
      <award-group id="award001">
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
            <institution>National Institute of Allergy and Infectious Diseases</institution>
          </institution-wrap>
        </funding-source>
        <award-id>K01AI130326</award-id>
        <principal-award-recipient>
          <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4942-3747</contrib-id>
          <name>
            <surname>Rogawski McQuade</surname>
            <given-names>Elizabeth T.</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
      <funding-statement>This work was supported by the National Institutes of Health, National Institute of Allergy and Infectious Diseases (grant K01AI130326 to ETRM; <ext-link xlink:href="https://www.niaid.nih.gov/" ext-link-type="uri">https://www.niaid.nih.gov/</ext-link>). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
    </funding-group>
    <counts>
      <fig-count count="2"/>
      <table-count count="2"/>
      <page-count count="13"/>
    </counts>
    <custom-meta-group>
      <custom-meta id="data-availability">
        <meta-name>Data Availability</meta-name>
        <meta-value>The package can be downloaded from the Comprehensive R Archive Network (CRAN) version 1.0.0 at <ext-link xlink:href="https://CRAN.R-project.org/package=riskCommunicator" ext-link-type="uri">https://CRAN.R-project.org/package=riskCommunicator</ext-link>. A development version, issue logging, and support can be found at <ext-link xlink:href="https://github.com/jgrembi/riskCommunicator" ext-link-type="uri">https://github.com/jgrembi/riskCommunicator</ext-link>. The package includes two vignettes, one included as <xref rid="sec006" ref-type="sec">Supporting Information</xref> along with this manuscript and another targeted for new R users with additional details which can be downloaded from CRAN. The dataset (“framingham”) included in the package is from The Framingham Heart Study and its use for the purpose of this package was approved on 11 March 2019 (request #7161) by the National Institutes of Health/National Heart, Lung, and Blood Institute. This is a teaching dataset and specific methods were employed to ensure an anonymous dataset that protects patient confidentiality.</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
  <notes>
    <title>Data Availability</title>
    <p>The package can be downloaded from the Comprehensive R Archive Network (CRAN) version 1.0.0 at <ext-link xlink:href="https://CRAN.R-project.org/package=riskCommunicator" ext-link-type="uri">https://CRAN.R-project.org/package=riskCommunicator</ext-link>. A development version, issue logging, and support can be found at <ext-link xlink:href="https://github.com/jgrembi/riskCommunicator" ext-link-type="uri">https://github.com/jgrembi/riskCommunicator</ext-link>. The package includes two vignettes, one included as <xref rid="sec006" ref-type="sec">Supporting Information</xref> along with this manuscript and another targeted for new R users with additional details which can be downloaded from CRAN. The dataset (“framingham”) included in the package is from The Framingham Heart Study and its use for the purpose of this package was approved on 11 March 2019 (request #7161) by the National Institutes of Health/National Heart, Lung, and Blood Institute. This is a teaching dataset and specific methods were employed to ensure an anonymous dataset that protects patient confidentiality.</p>
  </notes>
</front>
<body>
  <sec sec-type="intro" id="sec001">
    <title>Background</title>
    <p>The communication of disease risk and the effects of exposures and interventions on that risk are core components of public health research and practice. Unfortunately, reporting of results from epidemiologic studies both in the published scientific literature and to the public is often confused by imprecise language, jargon, and incomplete reporting [<xref rid="pone.0265368.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0265368.ref002" ref-type="bibr">2</xref>]. While it may be easy to rely on the default output from standard functions in statistical programs, common statistical methods estimate parameters that are often not the most informative. Epidemiologists and the larger community of public health practitioners could benefit from easy-to-use tools to facilitate the presentation of relevant effects.</p>
    <p>Overreliance on the odds ratio [<xref rid="pone.0265368.ref003" ref-type="bibr">3</xref>–<xref rid="pone.0265368.ref006" ref-type="bibr">6</xref>] and more broadly on relative effect measures [<xref rid="pone.0265368.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0265368.ref008" ref-type="bibr">8</xref>] are two examples of opportunities to improve the reporting and interpretability of epidemiologic results. Efforts to increase the reporting of difference effect measures and risk ratios over odds ratios are not new, and several solutions have been previously proposed, including changing the distribution of the response variable in generalized linear models (log-binomial, log-linear, and Poisson regression to approximate log-binomial regression when the latter does not converge [<xref rid="pone.0265368.ref009" ref-type="bibr">9</xref>]), standardization-based approaches [<xref rid="pone.0265368.ref010" ref-type="bibr">10</xref>], linear-expit regression [<xref rid="pone.0265368.ref011" ref-type="bibr">11</xref>], and ordinary least-squares regression with transformed variables [<xref rid="pone.0265368.ref012" ref-type="bibr">12</xref>]. However, these models are not as efficient as logistic regression, can have convergence problems, and may require robust variance estimators [<xref rid="pone.0265368.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0265368.ref013" ref-type="bibr">13</xref>].</p>
    <p>Parametric g-computation is an attractive alternative because of the flexibility to estimate a variety of effect measures while relying on the preferable statistical properties of logistic regression for the parametric modeling. G-computation is conceptually equivalent to standardization, and the use of parametric models allows for highly-dimensional data and continuous covariates. G-computation has been applied to estimate risk differences and risk ratios from logistic regression models previously [<xref rid="pone.0265368.ref014" ref-type="bibr">14</xref>–<xref rid="pone.0265368.ref016" ref-type="bibr">16</xref>].</p>
    <p>Despite the availability of g-computation-based methods, these methods are rarely used to estimate risk differences and risk ratios in standard time-fixed study designs. Recent applications of these methods have focused on complicated study designs, such as with longitudinal data with time-varying confounding affected by prior exposure [<xref rid="pone.0265368.ref017" ref-type="bibr">17</xref>]. In these applications, the methods are complex and difficult to understand and/or implement for the average data analyst. Coding requirements and computational limitations may also dissuade users from attempting these methods. Recently available R packages [<xref rid="pone.0265368.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0265368.ref019" ref-type="bibr">19</xref>] and Statistical Analysis System (SAS) macros [<xref rid="pone.0265368.ref020" ref-type="bibr">20</xref>] are geared towards estimating these more complicated effects and may be overwhelming to new users.</p>
    <p>We aimed to create a straightforward R package, called riskCommunicator, to facilitate the presentation of a variety of effect measures, including risk differences and ratios, number needed to treat, incidence rate differences and ratios, and mean differences, using g-computation. To make the package accessible to a broad range of health researchers, our goal was to design functions that were as easy to use as the standard logistic regression functions in R (e.g. glm) and that would require little to no expertise in causal inference methods or advanced coding.</p>
  </sec>
  <sec id="sec002">
    <title>Implementation</title>
    <p>The riskCommunicator package uses g-computation [<xref rid="pone.0265368.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0265368.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0265368.ref021" ref-type="bibr">21</xref>, <xref rid="pone.0265368.ref022" ref-type="bibr">22</xref>] with standard parametric regression models and bootstrapping for confidence intervals to estimate effect measures in the context of time-fixed exposure and outcome data. Broadly, the effects estimated are average treatment effects (ATEs), estimated for difference measures with a binary exposure variable as:
<disp-formula id="pone.0265368.e001"><alternatives><graphic xlink:href="pone.0265368.e001.jpg" id="pone.0265368.e001g" position="anchor"/><mml:math id="M1" display="block" overflow="scroll"><mml:mrow><mml:msub><mml:mi>φ</mml:mi><mml:mrow><mml:mtext>ATE</mml:mtext></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mstyle displaystyle="true"><mml:munder><mml:mo>∑</mml:mo><mml:mi>w</mml:mi></mml:munder><mml:mrow><mml:mo stretchy="false">[</mml:mo><mml:mtext>E</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>Y</mml:mtext><mml:mfenced close="" open="|"><mml:mrow><mml:mtext>A</mml:mtext><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mtext>W</mml:mtext><mml:mo>=</mml:mo><mml:mi>w</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mtext>E</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>Y</mml:mtext><mml:mfenced close="" open="|"><mml:mrow><mml:mtext>A</mml:mtext><mml:mo>=</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mtext>W</mml:mtext><mml:mo>=</mml:mo><mml:mi>w</mml:mi></mml:mrow></mml:mfenced><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">]</mml:mo><mml:mo>*</mml:mo><mml:mtext>Pr</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>W</mml:mtext><mml:mo>=</mml:mo><mml:mi>w</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mstyle></mml:mrow></mml:math></alternatives></disp-formula>
where Y is the outcome of interest, A is the exposure of interest, and W are covariates. In this way, the effects are standardized to the joint distribution of covariates in the total study population. Generalized linear models are used to estimate the counterfactual outcomes in the formula above, allowing for continuous covariates W.</p>
    <p>The package contains two main functions available to end users: gComp (the primary function) and pointEstimate (used internally within the gComp function, but provided to users in case of complex dependencies among observations, e.g. nested clusters-within-clusters, where a single cluster-level bootstrap resampling might not be optimal). pointEstimate computes a point estimate by executing three steps of g-computation. First, a regression of the outcome on the exposure and relevant covariates is fit using the provided dataset with a generalized linear model. The underlying model distribution is based on the outcome type supplied by the user (see outcome.type in <xref rid="pone.0265368.t001" ref-type="table">Table 1</xref> for details). Next, using the estimated parameters from the model, counterfactual outcomes are predicted for each observation in the data set under each level of the exposure. Finally, the mean predicted value for each exposure regime across all observations is calculated and used to estimate marginal difference and ratio effects. The gComp function first estimates effects in the original data (using the pointEstimate function). Then, bootstrap resampling of the original dataset is conducted, and the pointEstimate function is called on each resample in order to estimate accurate standard errors and provide a 95% confidence interval (CI). Confidence intervals are based on the 2.5<sup>th</sup> and 97.5<sup>th</sup> percentiles of the bootstrap resampling results [<xref rid="pone.0265368.ref023" ref-type="bibr">23</xref>].</p>
    <table-wrap position="float" id="pone.0265368.t001">
      <object-id pub-id-type="doi">10.1371/journal.pone.0265368.t001</object-id>
      <label>Table 1</label>
      <caption>
        <title>Arguments supplied to the gComp function in the riskCommunicator package.</title>
      </caption>
      <alternatives>
        <graphic xlink:href="pone.0265368.t001" id="pone.0265368.t001g" position="float"/>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1">Argument</th>
              <th align="left" rowspan="1" colspan="1">Description</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">data</td>
              <td align="left" rowspan="1" colspan="1">(Required) A data.frame or tibble containing variables for Y, X, and Z or with variables matching the model variables specified in a user-supplied formula. Data set should also contain variables for the optional subgroup and offset, if they are specified.</td>
            </tr>
            <tr>
              <td align="left" rowspan="13" colspan="1">outcome.type</td>
              <td align="left" rowspan="1" colspan="1">(Required) Character argument to describe the outcome type. Acceptable responses, and the corresponding error distribution and link function used in the glm, include:</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> <bold>binary</bold></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">  (Default) A binomial distribution with link = ‘logit’ is used. Function returns the risk difference, risk ratio, odds ratio, and number needed to treat/harm.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> <bold>count</bold></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">  A Poisson distribution with link = ‘log’ is used. Function returns the incidence rate difference and incidence rate ratio.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> <bold>count_nb</bold></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">  A negative binomial distribution with link = ‘log’ is used, where the theta parameter is estimated internally; ideal for over-dispersed count data. Function returns the incidence rate difference and incidence rate ratio.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> <bold>rate</bold></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">  A Poisson distribution with link = ‘log’ is used; ideal for events/person-time outcomes. Function returns the incidence rate difference and incidence rate ratio.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> <bold>rate_nb</bold></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">  A negative binomial distribution with link = ‘log’ is used, where the theta parameter is estimated internally; ideal for over-dispersed events/person-time outcomes. Function returns the incidence rate difference and incidence rate ratio.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1"> <bold>continuous</bold></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">  A gaussian distribution with link = ‘identity’ is used. Function returns the mean difference.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">formula</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default NULL (i.e. argument is optional). An object of class “formula” (or one that can be coerced to that class) which provides the complete model formula, similar to the formula for the glm function in R (e.g. ‘Y ~ X + Z1 + Z2 + Z3’). Can be supplied as a character or formula object. If no formula is provided, Y and X must be provided.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Y</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default NULL (i.e. argument is optional). Character argument which specifies the outcome variable. Can optionally provide a formula instead of Y and X variables.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">X</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default NULL (i.e. argument is optional). Character argument which specifies the exposure variable (or treatment group assignment), which can be binary, categorical, or continuous. This variable can be supplied as a factor variable (for binary or categorical exposures) or a continuous variable. For binary/categorical exposures, X should be supplied as a factor with the lowest level set to the desired referent. Numeric variables are accepted, but will be centered. Character variables are not accepted and will throw an error. Can optionally provide a formula instead of Y and X variables.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Z</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default NULL (i.e. argument is optional). List or single character vector which specifies the names of covariates or other variables to adjust for in the glm function. All variables should either be factors, continuous, or coded 0/1 (i.e. not character variables). Does not allow interaction terms.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">subgroup</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default NULL (i.e. argument is optional). Character argument that indicates subgroups for stratified analysis. Effects will be reported for each category of the subgroup variable. Variable will be automatically converted to a factor if not already.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">offset</td>
              <td align="left" rowspan="1" colspan="1">(Optional, only applicable for rate/count outcomes) Default NULL (i.e. argument is optional). Character argument which specifies the person-time denominator for rate outcomes to be included as an offset in the Poisson regression model. Numeric variable should be on the linear scale; function will take natural log before including in the model.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">rate.multiplier</td>
              <td align="left" rowspan="1" colspan="1">(Optional, only applicable for rate/count outcomes) Default 1. Numeric variable signifying the person-time value to use in predictions; the offset variable will be set to this when predicting under the counterfactual conditions. This value should be set to the person-time denominator desired for the rate difference measure and must be inputted in the units of the original offset variable (e.g. if the offset variable is in days and the desired rate difference is the rate per 100 person-years, rate.multiplier should be inputted as 365.25*100).</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">exposure.scalar</td>
              <td align="left" rowspan="1" colspan="1">(Optional, only applicable for continuous exposure) Default 1. Numeric value to scale effects with a continuous exposure. This option facilitates reporting effects for an interpretable contrast (i.e. magnitude of difference) within the continuous exposure. For example, if the continuous exposure is age in years, a multiplier of 10 would result in estimates per 10-year increase in age rather than per a 1-year increase in age.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">exposure.center</td>
              <td align="left" rowspan="1" colspan="1">(Optional, only applicable for continuous exposure) Default TRUE. Logical or numeric value to center a continuous exposure. This option facilitates reporting effects at the mean value of the exposure variable, and allows for a mean value to be provided directly to the function in cases where bootstrap resampling is being conducted and a standardized centering value should be used across all bootstraps. See note below on continuous exposure variables for additional details.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">R</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default 200. The number of data resamples to be conducted to produce the bootstrap confidence interval of the estimate.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">clusterID</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default NULL (i.e. argument is optional). Character argument which specifies the variable name for the unique identifier for clusters. This option specifies that clustering should be accounted for in the calculation of confidence intervals. The clusterID will be used as the level for resampling in the bootstrap procedure.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">parallel</td>
              <td align="left" rowspan="1" colspan="1">(Optional) Default “no.” The type of parallel operation to be used. Available options (besides the default of no parallel processing) include “multicore” (not available for Windows) or “snow.” This argument is passed directly to boot. See note about setting seeds and parallel computing.</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">ncpus</td>
              <td align="left" rowspan="1" colspan="1">(Optional, only used if parallel is set to “multicore” or “snow”) Default 1. Integer argument for the number of CPUs available for parallel processing/ number of parallel operations to be used. This argument is passed directly to boot.</td>
            </tr>
          </tbody>
        </table>
      </alternatives>
    </table-wrap>
    <p>Most users will only need to call the gComp function to estimate the effects of interest. Arguments to be supplied are listed in <xref rid="pone.0265368.t001" ref-type="table">Table 1</xref> (and examples of how to call the function are provided below in the Results section and <xref rid="pone.0265368.s001" ref-type="supplementary-material">S1 Appendix</xref>). Users can supply individual variable names for the exposure, outcome, and covariates, or can provide a model formula. The gComp function (and also pointEstimate) does not allow for interaction terms, however subgroup analysis is possible by specifying the variable name in the dataset corresponding to the subgroup classification, which automatically adds an interaction term between the subgroup variable and the exposure to the model formula. Both functions also allow for the specification of a categorical (in addition to binary) exposure. In cases of single-level clustered data, the gComp function can conduct bootstrap resampling at the cluster, instead of individual sample, level by specifying the variable identifying the cluster in the clusterID argument.</p>
    <p>Output of the gComp function is a list with several pieces of data, including parameter estimates and 95% confidence intervals for the effect measures (e.g. for a binary outcome, this would include risk difference, risk ratio, odds ratio, and number needed to treat). Confidence intervals are not reported for the number needed to treat since methods to calculate them are not standardized and they are challenging to interpret when the confidence interval for the risk difference crosses the null [<xref rid="pone.0265368.ref024" ref-type="bibr">24</xref>, <xref rid="pone.0265368.ref025" ref-type="bibr">25</xref>]. The number needed to treat should be used primarily for communication. Additional output includes marginal mean predicted outcomes for each exposure level. Users can visualize the distribution of parameter estimates over all bootstrap resamples of the data by plotting the resulting data with the base R plot() call to the output of the gComp function, which provides a quantile-quantile plot [<xref rid="pone.0265368.ref026" ref-type="bibr">26</xref>] and histogram of all parameter estimates (see <xref rid="pone.0265368.s001" ref-type="supplementary-material">S1 Appendix</xref>).</p>
    <p>Bootstrap resampling is necessary to estimate accurate 95% confidence intervals for the population-standardized marginal effects obtained with g-computation, since the standard errors for the coefficients from the underlying parametric model (covariate-conditional effects) do not correspond to the parameters of interest [<xref rid="pone.0265368.ref016" ref-type="bibr">16</xref>, <xref rid="pone.0265368.ref022" ref-type="bibr">22</xref>]. We recommend setting the number of bootstrap resamples (R) to 1000 for the final analysis. However, this can result in potentially long runtimes, depending on the computing power of the user’s computer (&gt;30min). Thus, exploratory analyses can be conducted with a lower number of bootstraps (default is R = 200, which should compute on datasets of 5000–10000 observations in &lt;60s).</p>
    <p>Package code was written in R version 4.1.2 [<xref rid="pone.0265368.ref027" ref-type="bibr">27</xref>], and the package was built in RStudio [<xref rid="pone.0265368.ref028" ref-type="bibr">28</xref>] using devtools and roxygen2 to generate and populate the package documentation [<xref rid="pone.0265368.ref029" ref-type="bibr">29</xref>, <xref rid="pone.0265368.ref030" ref-type="bibr">30</xref>]. riskCommunicator is open-source and freely available on GitHub (<ext-link xlink:href="https://github.com/jgrembi/riskCommunicator" ext-link-type="uri">https://github.com/jgrembi/riskCommunicator</ext-link>) and Comprehensive R Archive Network (<ext-link xlink:href="https://CRAN.R-project.org/package=riskCommunicator" ext-link-type="uri">https://CRAN.R-project.org/package=riskCommunicator</ext-link>). Dependencies include the boot [<xref rid="pone.0265368.ref031" ref-type="bibr">31</xref>], dplyr [<xref rid="pone.0265368.ref032" ref-type="bibr">32</xref>], ggplot2 [<xref rid="pone.0265368.ref033" ref-type="bibr">33</xref>], gridExtra [<xref rid="pone.0265368.ref034" ref-type="bibr">34</xref>], magritter [<xref rid="pone.0265368.ref035" ref-type="bibr">35</xref>], MASS [<xref rid="pone.0265368.ref036" ref-type="bibr">36</xref>], purr [<xref rid="pone.0265368.ref037" ref-type="bibr">37</xref>], rlang [<xref rid="pone.0265368.ref038" ref-type="bibr">38</xref>]r, stats [<xref rid="pone.0265368.ref027" ref-type="bibr">27</xref>], tidyr [<xref rid="pone.0265368.ref039" ref-type="bibr">39</xref>], and tidyselect [<xref rid="pone.0265368.ref040" ref-type="bibr">40</xref>] R packages.</p>
  </sec>
  <sec sec-type="results" id="sec003">
    <title>Results</title>
    <p>We demonstrate the utility of riskCommunicator using the teaching data set from the Framingham Heart Study [<xref rid="pone.0265368.ref041" ref-type="bibr">41</xref>], a prospective cohort study of cardiovascular disease conducted in Framingham, Massachusetts. The use of these data for the purposes of this package were approved on 11 March 2019 (request #7161) by National Institutes of Health/National Heart, Lung, and Blood Institute. These data were altered prior to receipt by the authors to ensure an anonymous dataset that protects patient confidentiality. This project was deemed by the Institutional Review Board at Emory University to not be research with human subjects and therefore did not require IRB review or consent from participants. The following analysis was conducted among 4,240 participants who conducted a baseline exam and were free of prevalent coronary heart disease when they entered the study in 1956. Participants were followed for 24 years for the combined outcome of cardiovascular disease or death due to any cause. A reproducible workflow of the analyses presented below is included as Supporting Information (<xref rid="pone.0265368.s001" ref-type="supplementary-material">S1 Appendix</xref>) and is additionally available as one of the two vignettes highlighting the full range of analyses that are available with riskCommunicator on Comprehensive R Archive Network (CRAN) and GitHub (<ext-link xlink:href="https://github.com/jgrembi/riskCommunicator" ext-link-type="uri">https://github.com/jgrembi/riskCommunicator</ext-link>).</p>
    <p>A relatively straightforward research aim for these data would be to estimate the effect of having prevalent diabetes at the beginning of the study on the 24-year risk of cardiovascular disease or death, adjusting for the potential confounders, including patient’s age, sex, body mass index, smoking status (current smoker or not), and prevalence of hypertension. For a binary outcome, riskCommunicator estimates the risk difference, risk ratio, odds ratio, and number needed to treat. The output of the gComp function for this analysis as follows reports the strong effect of diabetes on cardiovascular disease and mortality (<xref rid="pone.0265368.t002" ref-type="table">Table 2</xref>):</p>
    <table-wrap position="float" id="pone.0265368.t002">
      <object-id pub-id-type="doi">10.1371/journal.pone.0265368.t002</object-id>
      <label>Table 2</label>
      <caption>
        <title>Effect of prevalent diabetes at the beginning of the study on the 24-year risk of cardiovascular disease or death among 4,240 participants in the Framingham Heart Study.</title>
      </caption>
      <alternatives>
        <graphic xlink:href="pone.0265368.t002" id="pone.0265368.t002g" position="float"/>
        <table frame="hsides" rules="groups">
          <colgroup span="1">
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
            <col align="left" valign="middle" span="1"/>
          </colgroup>
          <thead>
            <tr>
              <th align="left" rowspan="1" colspan="1"/>
              <th align="left" rowspan="1" colspan="1">riskCommunicator</th>
              <th align="left" rowspan="1" colspan="1">Standard regression models<xref rid="t002fn001" ref-type="table-fn">*</xref></th>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Effect measure</th>
              <th align="left" rowspan="1" colspan="1">Marginal effect estimate<xref rid="t002fn002" ref-type="table-fn"><sup>†</sup></xref> (95% CI)</th>
              <th align="left" rowspan="1" colspan="1">Covariate-conditional effect estimate<xref rid="t002fn002" ref-type="table-fn"><sup>†</sup></xref> (95% CI)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Risk difference</td>
              <td align="left" rowspan="1" colspan="1">0.29 (0.20, 0.39)</td>
              <td align="left" rowspan="1" colspan="1">N/A<xref rid="t002fn003" ref-type="table-fn"><sup>‡</sup></xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Risk ratio</td>
              <td align="left" rowspan="1" colspan="1">1.70 (1.48, 1.97)</td>
              <td align="left" rowspan="1" colspan="1">1.49 (1.33, 1.66)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Odds ratio</td>
              <td align="left" rowspan="1" colspan="1">4.55 (2.77, 9.09)</td>
              <td align="left" rowspan="1" colspan="1">4.55 (2.66, 7.78)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Number needed to treat</td>
              <td align="left" rowspan="1" colspan="1">3.48</td>
              <td align="left" rowspan="1" colspan="1">N/A<xref rid="t002fn003" ref-type="table-fn"><sup>‡</sup></xref></td>
            </tr>
          </tbody>
        </table>
      </alternatives>
      <table-wrap-foot>
        <fn id="t002fn001">
          <p>*Log-linear regression for the risk difference, Poisson approximation of log-binomial regression with robust variance for the risk ratio, logistic regression for the odds ratio with Wald-based confidence intervals.</p>
        </fn>
        <fn id="t002fn002">
          <p>†Adjusted for patient’s age, sex, body mass index (BMI), smoking status (current smoker or not), and prevalence of hypertension.</p>
        </fn>
        <fn id="t002fn003">
          <p>‡Log-linear model did not converge.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <list list-type="simple">
      <list-item>
        <p specific-use="line">library(riskCommunicator)</p>
      </list-item>
      <list-item>
        <p specific-use="line">library(tidyverse)</p>
      </list-item>
      <list-item>
        <p specific-use="line">data(cvdd)</p>
      </list-item>
      <list-item>
        <p specific-use="line">set.seed(1298)</p>
      </list-item>
      <list-item>
        <p specific-use="line">binary.res &lt;- gComp(data = cvdd, Y = "cvd_dth", X = "DIABETES", Z = c("AGE", "SEX", "BMI", "CURSMOKE", "PREVHYP"), outcome.type = "binary", R = 1000)</p>
      </list-item>
    </list>
    <p>The absolute 24-year risk of cardiovascular disease or death due to any cause was 29% (95% CI: 20, 40) higher among subjects with diabetes at baseline compared to subjects without diabetes at baseline. The relative 24-year risk was 70% (95% CI: 48, 97) higher. Because the incidence of the outcome was high (41.8% experiencing cardiovascular disease or death due to any cause over 24 years), the odds ratio (4.55) does not approximate the risk ratio and rather is highly inflated compared to the risk ratio (1.70). This is a clear example where the odds ratio may be misleading since the odds ratio is commonly misinterpreted as a risk ratio. Furthermore, the relative effect may be interpreted as much larger than the absolute effect, even though the absolute risk difference more closely corresponds to the expected additional number of cases due to diabetes. For public health communication, the number needed to treat derived from the risk difference (1/risk difference) provides an easily interpreted estimate of the magnitude of effect. We would expect that only 4 additional persons would need to have diabetes at baseline to observe an increase in the number of cases of cardiovascular disease or death by 1 over 24 years of follow-up.</p>
    <p>The 95% CIs obtained from the riskCommunicator package represent population-standardized marginal effects obtained with g-computation. We can check that the bootstrap results are normally distributed by plotting the output of the gComp function with the following command, which results in <xref rid="pone.0265368.g001" ref-type="fig">Fig 1</xref>:</p>
    <fig position="float" id="pone.0265368.g001">
      <object-id pub-id-type="doi">10.1371/journal.pone.0265368.g001</object-id>
      <label>Fig 1</label>
      <caption>
        <title>Histograms and quantile-quantile (Q-Q) plots of bootstrap iterations (R = 1000) obtained from the binary.res output for each effect measure.</title>
        <p>NOTE: All ratio values are plotted as natural log of the actual estimate.</p>
      </caption>
      <graphic xlink:href="pone.0265368.g001" position="float"/>
    </fig>
    <sec id="sec004">
      <title>plot(binary.res)</title>
      <p>The histograms show the different effect estimates obtained by each bootstrap resampling of the data and should be normally distributed if the model is correctly specified. Q-Q plots help to verify that the bootstrap values are normally distributed by comparing the actual distribution of bootstrap values against a theoretical normal distribution of values centered at mean = 0. If the estimates are normally distributed, the plotted estimates (black circles) should overlay the diagonal red dashed line.</p>
      <p>We may also be interested in the effect of diabetes on the rate of cardiovascular disease or death, incorporating person-time at risk. If the Framingham Heart Study were an open cohort with variable follow-up time, rate-based effects would be more appropriate than risk-based measures, which assume a constant follow-up period. In addition, we may be interested in effects stratified by a potential effect measure modifier, such as participant sex. riskCommunicator can estimate the incidence rate difference and incidence rate ratio by sex for this analysis (<xref rid="pone.0265368.g002" ref-type="fig">Fig 2</xref>). As the person-time variable has units of days, rates are reported per 100 person-years by using the rate.multiplier option.</p>
      <fig position="float" id="pone.0265368.g002">
        <object-id pub-id-type="doi">10.1371/journal.pone.0265368.g002</object-id>
        <label>Fig 2</label>
        <caption>
          <title>Effect of having prevalent diabetes at the beginning of the study on the 24-year risk of cardiovascular disease or death overall and stratified by sex among 4,240 participants in the Framingham Heart Study.</title>
          <p>A) Incidence rate ratio. B) Incidence rate difference. riskCommunicator was used to obtain marginal effect estimates (purple) and Poisson regression was used to obtain covariate-conditional estimates (green; not available for incidence rate difference). All models were adjusted for patient’s age, sex, body mass index, smoking status (current smoker or not), and prevalence of hypertension. Each point represents the point estimate and error bars show the 95% CI.</p>
        </caption>
        <graphic xlink:href="pone.0265368.g002" position="float"/>
      </fig>
      <list list-type="simple">
        <list-item>
          <p specific-use="line">cvdd.t &lt;- cvdd %&gt;%</p>
        </list-item>
        <list-item>
          <p specific-use="line"> dplyr::mutate(cvd_dth = as.numeric(as.character(cvd_dth)),</p>
        </list-item>
        <list-item>
          <p specific-use="line">     timeout = as.numeric(timeout))</p>
        </list-item>
        <list-item>
          <p specific-use="line">set.seed(6534)</p>
        </list-item>
        <list-item>
          <p specific-use="line">rate.res &lt;- gComp(data = cvdd.t,</p>
        </list-item>
        <list-item>
          <p specific-use="line">      Y = "cvd_dth",</p>
        </list-item>
        <list-item>
          <p specific-use="line">      X = "DIABETES",</p>
        </list-item>
        <list-item>
          <p specific-use="line">      Z = c("AGE", "SEX", "BMI", "CURSMOKE", "PREVHYP"),</p>
        </list-item>
        <list-item>
          <p specific-use="line">      outcome.type = "rate",</p>
        </list-item>
        <list-item>
          <p specific-use="line">      rate.multiplier = 365.25*100,</p>
        </list-item>
        <list-item>
          <p specific-use="line">      offset = "timeout",</p>
        </list-item>
        <list-item>
          <p specific-use="line">      R = 1000)</p>
        </list-item>
        <list-item>
          <p specific-use="line">rate.res.subgroup &lt;- gComp(data = cvdd.t, Y = "cvd_dth", X = "DIABETES", Z = c("AGE", "SEX", "BMI", "CURSMOKE", "PREVHYP"), subgroup = "SEX", outcome.type = "rate", rate.multiplier = 365.25*100, offset = "timeout", R = 1000)</p>
        </list-item>
      </list>
      <p>There is evidence for effect modification on the additive scale. The absolute rate of cardiovascular disease or death due to any cause is 2.49 cases/100 person-years (95% CI: 1.34, 4.06) higher among males with diabetes compared to males without diabetes. In contrast, the effect among women is smaller: the absolute rate of cardiovascular disease or death is 1.92 cases/100 person-years (95% CI: 1.00, 3.32) higher among females with diabetes compared to females without diabetes. The relative effects suggest effect modification in the opposite direction on the multiplicative scale, such that the effect of diabetes is stronger among females compared to males. This difference is observed because the baseline rate of cardiovascular disease and death without diabetes is higher among males (2.77 cases/100 person-years) than females (1.64 cases/100 person-years), such that with the relative effect, the greater absolute effect among males is diluted by their higher baseline risk.</p>
      <p>The overall incidence rate ratio in the total study population (1.91, 95% CI: 1.60, 2.29) can be estimated using the same code as above without the subgroup option. As expected, the incidence rate ratio is further from the null than the risk ratio, but closer to the null than the odds ratio (<xref rid="pone.0265368.t001" ref-type="table">Table 1</xref>). This relationship among the magnitudes of these effect measures is expected due to their mathematical properties, and specifically the differences in the denominators of risk (total population), rates (person-time at risk), and odds (non-cases at the end of follow-up).</p>
      <p>The estimation of these effects with standard regression models is not trivial. To estimate the risk difference and risk ratio, we used log-binomial and log-linear regression, respectively. However, in these data, both models fail to converge, and the Poisson approximation with robust variance was necessary to estimate the risk ratio. The risk ratio estimate from g-computation (confidence limit ratio: 1.33) had slightly lower precision compared to the estimate from Poisson regression with robust variance (confidence limit ratio: 1.25). Minor differences in the magnitude of the estimates can be attributed to the difference between the covariate-conditional effects (as estimated by Poisson regression) and the marginal effects (as estimated by riskCommunicator; <xref rid="pone.0265368.t002" ref-type="table">Table 2</xref>). Poisson regression could also be used to estimate the incidence rate ratios, resulting in equivalent magnitudes of estimates as those from riskCommunicator, but slightly less precision. Adjusted incidence rate differences are not easy to estimate using standard regression models, but are readily available from riskCommunicator.</p>
      <p>Finally, an additional useful output of the package is the estimation of marginal mean predicted outcomes for each exposure level. These predicted means are standardized over the observed values of covariates included in the model, and therefore are not specific to set values of the covariates. This difference is a major advantage over the usual predict function in R, and similar functions in other statistical programs such as the lsmeans statement in Statistical Analysis System (SAS), which can only predict outcomes at specific values of the other covariates.</p>
    </sec>
  </sec>
  <sec sec-type="conclusions" id="sec005">
    <title>Conclusions</title>
    <p>riskCommunicator facilitates the presentation of a wide range of effect measures with a simple user experience, similar to running a linear regression model in R. For binary outcomes, effects are modeled using logistic regression, which preserves the preferable statistical qualities usually associated with odds ratios and applies them to the estimation of risk ratios and risk differences. The package also facilitates the presentation of incidence rate differences, which are difficult to obtain with standard generalized linear models. Finally, the package supports assessment of additive effect measure modification by reporting difference effects, which is important since contradictory evidence for effect modification between the additive and multiplicative scales is common. While effect modification on the additive scale can be more relevant to public health [<xref rid="pone.0265368.ref042" ref-type="bibr">42</xref>, <xref rid="pone.0265368.ref043" ref-type="bibr">43</xref>], it is often harder to estimate with standard regression models [<xref rid="pone.0265368.ref044" ref-type="bibr">44</xref>, <xref rid="pone.0265368.ref045" ref-type="bibr">45</xref>].</p>
    <p>It is important to highlight that the g-computation approach produces marginal rather than covariate-conditional effect estimates. In a multivariable model, the effect estimates derived directly from the covariate coefficients are covariate-conditional, interpreted as the associations given constant values of the other variables (or informally, “holding all other variables constant”) [<xref rid="pone.0265368.ref042" ref-type="bibr">42</xref>]. Covariate-conditional effects are difficult to interpret for non-collapsible effect measures like the odds ratio [<xref rid="pone.0265368.ref046" ref-type="bibr">46</xref>]. Therefore, the reporting of marginal effects, in which the effect is standardized over the covariate distribution of the total study population, may be preferable in many cases. The marginal effect is interpreted as the average treatment effect in the total population and is the primary effect of interest in randomized trials and in many observational settings where causal inference is the goal [<xref rid="pone.0265368.ref047" ref-type="bibr">47</xref>].</p>
    <p>One potential limitation to the g-computation approach is the use of bootstrap for the confidence intervals. Bootstrapping is conservative compared to closed form solutions for the variance (e.g. those used to estimate Wald confidence intervals), such that the confidence intervals from bootstrapping can be slightly wider than alternatives. However, in the examples above, precision improved for the rate ratios. In addition, the precision loss is often not extreme when it occurs, and bootstrapped confidence intervals are more appropriate when the distributional assumptions or approximations of the parameter, such as the normal approximation to the binomial distribution employed with Wald-based confidence intervals, may not be valid [<xref rid="pone.0265368.ref042" ref-type="bibr">42</xref>]. By using percentiles of the simulated distribution of estimates from the bootstrap, one can avoid the need to calculate the standard deviation of estimates under the normal distribution assumption [<xref rid="pone.0265368.ref048" ref-type="bibr">48</xref>]. The use of bootstrap allows for flexibility to estimate many effects with the same framework, including allowing for clustering with bootstrap at the cluster level.</p>
    <p>The g-computation approach can also be limited in settings with a continuous exposure variable. For example, for a binary outcome, because the underlying parametric model is logistic regression, the risks will be estimated to be linear on the log-odds (logit) scale, such that the odds ratio for any one unit increase in the continuous variable is constant. However, the risks will not be linear on the linear (risk difference) or log (risk ratio) scales, such that these parameters will not be constant across the range of the continuous exposure. The g-computation approach requires setting one specific exposure contrast within the range of the continuous exposure. Therefore, users should be aware that the risk difference, risk ratio, number needed to treat (for a binary outcome) and the incidence rate difference (for a rate/count outcome) reported do not necessarily apply across the entire range of the continuous exposure. We mitigate this issue by reporting the estimates for a relevant contrast within the exposure variable by first centering the variable at the mean and allowing users to specify a scaling factor for the contrast.</p>
    <p>While other software packages are available to conduct more complex analyses with the g-computation approach, riskCommunicator has been designed to be more accessible to the average data analyst. For example, the GFORMULA macro for SAS [<xref rid="pone.0265368.ref020" ref-type="bibr">20</xref>] and the gfoRmula package in R [<xref rid="pone.0265368.ref018" ref-type="bibr">18</xref>] are targeted to longitudinal data with time-varying covariates. The qgcomp package combines g-computation with weighted quantile sum regression to estimate the effects of mixtures [<xref rid="pone.0265368.ref049" ref-type="bibr">49</xref>]. The tmle3 package in R includes g-computation but is designed to enable a more comprehensive set of analyses to estimate Targeted Minimum Loss-Based Estimation (TMLE) parameters [<xref rid="pone.0265368.ref019" ref-type="bibr">19</xref>], which requires advanced training even for doctoral-level epidemiologists. The focus of riskCommunicator alternatively is on facilitating the presentation of relevant and interpretable effect measures in relatively simple time-fixed settings. The application of g-computation in these more traditional settings can help overcome the gap for less experienced users between traditional regression modeling-based methods and the g-methods, which are at the vanguard of epidemiologic methods development [<xref rid="pone.0265368.ref050" ref-type="bibr">50</xref>]. More importantly, riskCommunicator can facilitate the communication of effects of exposures and interventions and ultimately further the public health impact of epidemiologic and statistical research.</p>
  </sec>
  <sec id="sec006" sec-type="supplementary-material">
    <title>Supporting information</title>
    <supplementary-material id="pone.0265368.s001" position="float" content-type="local-data">
      <label>S1 Appendix</label>
      <caption>
        <title>Vignette containing all code needed to reproduce analyses, tables and figures shown in the manuscript.</title>
        <p>(PDF)</p>
      </caption>
      <media xlink:href="pone.0265368.s001.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack>
    <p>We thank Dr. Charlie Poole for his feedback on key functions of the package. We thank Helen Pitchik and Solis Winters for beta testing and useful suggestions on formatting results for downstream plotting functionality.</p>
  </ack>
  <ref-list>
    <title>References</title>
    <ref id="pone.0265368.ref001">
      <label>1</label>
      <mixed-citation publication-type="journal"><name><surname>Pocock</surname><given-names>SJ</given-names></name>, <name><surname>Collier</surname><given-names>TJ</given-names></name>, <name><surname>Dandreo</surname><given-names>KJ</given-names></name>, <name><surname>de Stavola</surname><given-names>BL</given-names></name>, <name><surname>Goldman</surname><given-names>MB</given-names></name>, <name><surname>Kalish</surname><given-names>LA</given-names></name>, <etal>et al</etal>. <article-title>Issues in the reporting of epidemiological studies: a survey of recent practice</article-title>. <source>BMJ</source>. <year>2004</year>;<volume>329</volume>: <fpage>883</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.38250.571088.55</pub-id><?supplied-pmid 15469946?><pub-id pub-id-type="pmid">15469946</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref002">
      <label>2</label>
      <mixed-citation publication-type="journal"><name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <name><surname>von Elm</surname><given-names>E</given-names></name>, <name><surname>Altman</surname><given-names>DG</given-names></name>, <name><surname>Gøtzsche</surname><given-names>PC</given-names></name>, <name><surname>Mulrow</surname><given-names>CD</given-names></name>, <name><surname>Pocock</surname><given-names>SJ</given-names></name>, <etal>et al</etal>. <article-title>Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration</article-title>. <source>Epidemiology</source>. <year>2007</year>;<volume>18</volume>: <fpage>805</fpage>–<lpage>835</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/EDE.0b013e3181577511</pub-id><?supplied-pmid 18049195?><pub-id pub-id-type="pmid">18049195</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref003">
      <label>3</label>
      <mixed-citation publication-type="journal"><name><surname>Knol</surname><given-names>MJ</given-names></name>, <name><surname>Le Cessie</surname><given-names>S</given-names></name>, <name><surname>Algra</surname><given-names>A</given-names></name>, <name><surname>Vandenbroucke</surname><given-names>JP</given-names></name>, <name><surname>Groenwold</surname><given-names>RHH</given-names></name>. <article-title>Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression</article-title>. <source>Canadian Medical Association Journal</source>. <year>2012</year>;<volume>184</volume>: <fpage>895</fpage>–<lpage>899</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1503/cmaj.101715</pub-id><?supplied-pmid 22158397?><pub-id pub-id-type="pmid">22158397</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref004">
      <label>4</label>
      <mixed-citation publication-type="journal"><name><surname>Holcomb</surname><given-names>WL</given-names></name>, <name><surname>Chaiworapongsa</surname><given-names>T</given-names></name>, <name><surname>Luke</surname><given-names>DA</given-names></name>, <name><surname>Burgdorf</surname><given-names>KD</given-names></name>. <article-title>An odd measure of risk: use and misuse of the odds ratio</article-title>. <source>Obstet Gynecol</source>. <year>2001</year>;<volume>98</volume>: <fpage>685</fpage>–<lpage>688</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0029-7844(01)01488-0</pub-id><?supplied-pmid 11576589?><pub-id pub-id-type="pmid">11576589</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref005">
      <label>5</label>
      <mixed-citation publication-type="journal"><name><surname>Persoskie</surname><given-names>A</given-names></name>, <name><surname>Ferrer</surname><given-names>RA</given-names></name>. <article-title>A Most Odd Ratio</article-title>. <source>Am J Prev Med</source>. <year>2017</year>;<volume>52</volume>: <fpage>224</fpage>–<lpage>228</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.amepre.2016.07.030</pub-id><?supplied-pmid 27639787?><pub-id pub-id-type="pmid">27639787</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref006">
      <label>6</label>
      <mixed-citation publication-type="journal"><name><surname>Katz</surname><given-names>KA</given-names></name>. <article-title>The (Relative) Risks of Using Odds Ratios</article-title>. <source>Arch Dermatol</source>. <year>2006</year>;<volume>142</volume>: <fpage>761</fpage>–<lpage>764</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1001/archderm.142.6.761</pub-id><?supplied-pmid 16785380?><pub-id pub-id-type="pmid">16785380</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref007">
      <label>7</label>
      <mixed-citation publication-type="journal"><name><surname>Schwartz</surname><given-names>LM</given-names></name>, <name><surname>Woloshin</surname><given-names>S</given-names></name>, <name><surname>Dvorin</surname><given-names>EL</given-names></name>, <name><surname>Welch</surname><given-names>HG</given-names></name>. <article-title>Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks</article-title>. <source>BMJ</source>. <year>2006</year>;<volume>333</volume>: <fpage>1248</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1136/bmj.38985.564317.7C</pub-id><?supplied-pmid 17060338?><pub-id pub-id-type="pmid">17060338</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref008">
      <label>8</label>
      <mixed-citation publication-type="journal"><name><surname>Noordzij</surname><given-names>M</given-names></name>, <name><surname>van Diepen</surname><given-names>M</given-names></name>, <name><surname>Caskey</surname><given-names>FC</given-names></name>, <name><surname>Jager</surname><given-names>KJ</given-names></name>. <article-title>Relative risk versus absolute risk: one cannot be interpreted without the other</article-title>. <source>Nephrol Dial Transplant</source>. <year>2017</year>;<volume>32</volume>: <fpage>ii13</fpage>–<lpage>ii18</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ndt/gfw465</pub-id><?supplied-pmid 28339913?><pub-id pub-id-type="pmid">28339913</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref009">
      <label>9</label>
      <mixed-citation publication-type="journal"><name><surname>Zou</surname><given-names>G.</given-names></name><article-title>A modified poisson regression approach to prospective studies with binary data</article-title>. <source>Am J Epidemiol</source>. <year>2004</year>;<volume>159</volume>: <fpage>702</fpage>–<lpage>706</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwh090</pub-id><?supplied-pmid 15033648?><pub-id pub-id-type="pmid">15033648</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref010">
      <label>10</label>
      <mixed-citation publication-type="journal"><name><surname>Greenland</surname><given-names>S.</given-names></name><article-title>Estimating standardized parameters from generalized linear models</article-title>. <source>Stat Med</source>. <year>1991</year>;<volume>10</volume>: <fpage>1069</fpage>–<lpage>1074</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.4780100707</pub-id><?supplied-pmid 1876795?><pub-id pub-id-type="pmid">1876795</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref011">
      <label>11</label>
      <mixed-citation publication-type="journal"><name><surname>Kovalchik</surname><given-names>SA</given-names></name>, <name><surname>Varadhan</surname><given-names>R</given-names></name>, <name><surname>Fetterman</surname><given-names>B</given-names></name>, <name><surname>Poitras</surname><given-names>NE</given-names></name>, <name><surname>Wacholder</surname><given-names>S</given-names></name>, <name><surname>Katki</surname><given-names>HA</given-names></name>. <article-title>A general binomial regression model to estimate standardized risk differences from binary response data</article-title>. <source>Stat Med</source>. <year>2013</year>;<volume>32</volume>: <fpage>808</fpage>–<lpage>821</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.5553</pub-id><?supplied-pmid 22865328?><pub-id pub-id-type="pmid">22865328</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref012">
      <label>12</label>
      <mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>Y</given-names></name>, <name><surname>Cheung</surname><given-names>YB</given-names></name>, <name><surname>Lam</surname><given-names>KF</given-names></name>, <name><surname>Tan</surname><given-names>SH</given-names></name>, <name><surname>Milligan</surname><given-names>P</given-names></name>. <article-title>A Simple Approach to the Estimation of Incidence Rate Difference</article-title>. <source>Am J Epidemiol</source>. <year>2010</year>;<volume>172</volume>: <fpage>334</fpage>–<lpage>343</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwq099</pub-id><?supplied-pmid 20606039?><pub-id pub-id-type="pmid">20606039</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref013">
      <label>13</label>
      <mixed-citation publication-type="journal"><name><surname>Yelland</surname><given-names>LN</given-names></name>, <name><surname>Salter</surname><given-names>AB</given-names></name>, <name><surname>Ryan</surname><given-names>P</given-names></name>. <article-title>Relative Risk Estimation in Randomized Controlled Trials: A Comparison of Methods for Independent Observations</article-title>. <source>The International Journal of Biostatistics</source>. <year>2011</year>;<volume>7</volume>: <fpage>1</fpage>–<lpage>31</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2202/1557-4679.1278</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref014">
      <label>14</label>
      <mixed-citation publication-type="journal"><name><surname>Localio</surname><given-names>AR</given-names></name>, <name><surname>Margolis</surname><given-names>DJ</given-names></name>, <name><surname>Berlin</surname><given-names>JA</given-names></name>. <article-title>Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression</article-title>. <source>J Clin Epidemiol</source>. <year>2007</year>;<volume>60</volume>: <fpage>874</fpage>–<lpage>882</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jclinepi.2006.12.001</pub-id><?supplied-pmid 17689803?><pub-id pub-id-type="pmid">17689803</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref015">
      <label>15</label>
      <mixed-citation publication-type="journal"><name><surname>Bieler</surname><given-names>GS</given-names></name>, <name><surname>Brown</surname><given-names>GG</given-names></name>, <name><surname>Williams</surname><given-names>RL</given-names></name>, <name><surname>Brogan</surname><given-names>DJ</given-names></name>. <article-title>Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data</article-title>. <source>Am J Epidemiol</source>. <year>2010</year>;<volume>171</volume>: <fpage>618</fpage>–<lpage>623</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwp440</pub-id><?supplied-pmid 20133516?><pub-id pub-id-type="pmid">20133516</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref016">
      <label>16</label>
      <mixed-citation publication-type="journal"><name><surname>Ahern</surname><given-names>J</given-names></name>, <name><surname>Hubbard</surname><given-names>A</given-names></name>, <name><surname>Galea</surname><given-names>S</given-names></name>. <article-title>Estimating the effects of potential public health interventions on population disease burden: a step-by-step illustration of causal inference methods</article-title>. <source>Am J Epidemiol</source>. <year>2009</year>;<volume>169</volume>: <fpage>1140</fpage>–<lpage>1147</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwp015</pub-id><?supplied-pmid 19270051?><pub-id pub-id-type="pmid">19270051</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref017">
      <label>17</label>
      <mixed-citation publication-type="journal"><name><surname>Westreich</surname><given-names>D</given-names></name>, <name><surname>Cole</surname><given-names>SR</given-names></name>, <name><surname>Young</surname><given-names>JG</given-names></name>, <name><surname>Palella</surname><given-names>F</given-names></name>, <name><surname>Tien</surname><given-names>PC</given-names></name>, <name><surname>Kingsley</surname><given-names>L</given-names></name>, <etal>et al</etal>. <article-title>The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death</article-title>. <source>Stat Med</source>. <year>2012</year>;<volume>31</volume>: <fpage>2000</fpage>–<lpage>2009</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/sim.5316</pub-id><?supplied-pmid 22495733?><pub-id pub-id-type="pmid">22495733</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref018">
      <label>18</label>
      <mixed-citation publication-type="other">Lin V, McGrath S, Zhang Z, Logan RW, Petito LC, Young JC, et al. gfoRmula: Parametric G-formula. 30 Jan 2020 [cited 7 Feb 2020]. Available: <ext-link xlink:href="https://cran.r-project.org/web/packages/gfoRmula/index.html" ext-link-type="uri">https://cran.r-project.org/web/packages/gfoRmula/index.html</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref019">
      <label>19</label>
      <mixed-citation publication-type="other">Coyle J. R/tmle: The Extensible TMLE framework. [cited 7 Feb 2020]. Available: <ext-link xlink:href="https://tlverse.org/tmle3/" ext-link-type="uri">https://tlverse.org/tmle3/</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref020">
      <label>20</label>
      <mixed-citation publication-type="other">Harvard Program on Causal Inference: Software. [cited 7 Feb 2020]. Available: <ext-link xlink:href="https://www.hsph.harvard.edu/causal/software/" ext-link-type="uri">https://www.hsph.harvard.edu/causal/software/</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref021">
      <label>21</label>
      <mixed-citation publication-type="journal"><name><surname>Robins</surname><given-names>J.</given-names></name><article-title>A new approach to causal inference in mortality studies with a sustained exposure period—application to control of the healthy worker survivor effect</article-title>. <source>Mathematical Modelling</source>. <year>1986</year>;<volume>7</volume>: <fpage>1393</fpage>–<lpage>1512</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/0270-0255(86)90088-6</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref022">
      <label>22</label>
      <mixed-citation publication-type="journal"><name><surname>Snowden</surname><given-names>JM</given-names></name>, <name><surname>Rose</surname><given-names>S</given-names></name>, <name><surname>Mortimer</surname><given-names>KM</given-names></name>. <article-title>Implementation of G-computation on a simulated data set: demonstration of a causal inference technique</article-title>. <source>Am J Epidemiol</source>. <year>2011</year>;<volume>173</volume>: <fpage>731</fpage>–<lpage>738</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwq472</pub-id><?supplied-pmid 21415029?><pub-id pub-id-type="pmid">21415029</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref023">
      <label>23</label>
      <mixed-citation publication-type="journal"><name><surname>Efron</surname><given-names>B</given-names></name>, <name><surname>Tibshirani</surname><given-names>R</given-names></name>. <article-title>Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy</article-title>. <source>Statistical Science</source>. <year>1986</year>;<volume>1</volume>: <fpage>54</fpage>–<lpage>75</lpage>.</mixed-citation>
    </ref>
    <ref id="pone.0265368.ref024">
      <label>24</label>
      <mixed-citation publication-type="journal"><name><surname>Hutton</surname><given-names>JL</given-names></name>. <article-title>Number needed to treat: properties and problems</article-title>. <source>Journal of the Royal Statistical Society: Series A (Statistics in Society)</source>. <year>2000</year>;<volume>163</volume>: <fpage>381</fpage>–<lpage>402</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1111/1467-985X.00175</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref025">
      <label>25</label>
      <mixed-citation publication-type="journal"><name><surname>Stang</surname><given-names>A</given-names></name>, <name><surname>Poole</surname><given-names>C</given-names></name>, <name><surname>Bender</surname><given-names>R</given-names></name>. <article-title>Common problems related to the use of number needed to treat</article-title>. <source>Journal of Clinical Epidemiology</source>. <year>2010</year>;<volume>63</volume>: <fpage>820</fpage>–<lpage>825</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jclinepi.2009.08.006</pub-id><?supplied-pmid 19880287?><pub-id pub-id-type="pmid">19880287</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref026">
      <label>26</label>
      <mixed-citation publication-type="journal"><name><surname>Wilk</surname><given-names>MB</given-names></name>, <name><surname>Gnanadesikan</surname><given-names>R</given-names></name>. <article-title>Probability Plotting Methods for the Analysis of Data</article-title>. <source>Biometrika</source>. <year>1968</year>;<volume>55</volume>: <fpage>1</fpage>–<lpage>17</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2307/2334448</pub-id><?supplied-pmid 5661047?><pub-id pub-id-type="pmid">5661047</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref027">
      <label>27</label>
      <mixed-citation publication-type="other">R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2013. Available: <ext-link xlink:href="http://www.R-project.org/" ext-link-type="uri">http://www.R-project.org/</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref028">
      <label>28</label>
      <mixed-citation publication-type="other">RStudio Team. RStudio: Integrated Development for R. Boston, MA: RStudio, Inc.; 2015. Available: <ext-link xlink:href="http://www.rstudio.com/" ext-link-type="uri">http://www.rstudio.com/</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref029">
      <label>29</label>
      <mixed-citation publication-type="other">Wickham H, Chang W. devtools: Tools to Make Developing R Packages Easier. 2017. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=devtools" ext-link-type="uri">https://CRAN.R-project.org/package=devtools</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref030">
      <label>30</label>
      <mixed-citation publication-type="other">Wickham H, Danenberg P, Eugster M. roxygen2: In-Line Documentation for R. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=roxygen2" ext-link-type="uri">https://CRAN.R-project.org/package=roxygen2</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref031">
      <label>31</label>
      <mixed-citation publication-type="other">Canty A, Ripley B. boot: Bootstrap R (S-Plus) Functions.</mixed-citation>
    </ref>
    <ref id="pone.0265368.ref032">
      <label>32</label>
      <mixed-citation publication-type="other">Wickham H, François R, Henry L, Müller K. dplyr: A Grammar of Data Manipulation. 2022. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=dplyr" ext-link-type="uri">https://CRAN.R-project.org/package=dplyr</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref033">
      <label>33</label>
      <mixed-citation publication-type="other">Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016. Available: <ext-link xlink:href="https://ggplot2.tidyverse.org" ext-link-type="uri">https://ggplot2.tidyverse.org</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref034">
      <label>34</label>
      <mixed-citation publication-type="other">Auguie B. gridExtra: Miscellaneous Functions for “Grid” Graphics. 2017. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=gridExtra" ext-link-type="uri">https://CRAN.R-project.org/package=gridExtra</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref035">
      <label>35</label>
      <mixed-citation publication-type="other">Bache SM, Wickham H. magrittr: A Forward-Pipe Operator for R. 2022. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=magrittr" ext-link-type="uri">https://CRAN.R-project.org/package=magrittr</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref036">
      <label>36</label>
      <mixed-citation publication-type="book"><name><surname>Venables</surname><given-names>WN</given-names></name>, <name><surname>Ripley</surname><given-names>BD</given-names></name>. <source>Modern Applied Statistics with S</source>. <edition designator="4">Fourth</edition>. <publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2002</year>. Available: <ext-link xlink:href="https://www.stats.ox.ac.uk/pub/MASS4/" ext-link-type="uri">https://www.stats.ox.ac.uk/pub/MASS4/</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref037">
      <label>37</label>
      <mixed-citation publication-type="other">Henry L, Wickham H. purrr: Functional Programming Tools. 2020. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=purrr" ext-link-type="uri">https://CRAN.R-project.org/package=purrr</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref038">
      <label>38</label>
      <mixed-citation publication-type="other">Henry L, Wickham H. rlang: Functions for Base Types and Core R and “Tudyverse” Features. 2022.</mixed-citation>
    </ref>
    <ref id="pone.0265368.ref039">
      <label>39</label>
      <mixed-citation publication-type="other">Wickham H, Girlich M. tidyr: Tidy Messy Data. 2022. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=tidyr" ext-link-type="uri">https://CRAN.R-project.org/package=tidyr</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref040">
      <label>40</label>
      <mixed-citation publication-type="other">Henry L, Wickham H. tidyselect: Select from a Set of Strings. 2021. Available: <ext-link xlink:href="https://CRAN.R-project.org/package=tidyselect" ext-link-type="uri">https://CRAN.R-project.org/package=tidyselect</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref041">
      <label>41</label>
      <mixed-citation publication-type="other">National Heart, Lunch, and Blood Institute. Teaching Datasets. [cited 11 Mar 2019]. Available: <ext-link xlink:href="https://biolincc.nhlbi.nih.gov/teaching/" ext-link-type="uri">https://biolincc.nhlbi.nih.gov/teaching/</ext-link></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref042">
      <label>42</label>
      <mixed-citation publication-type="book"><name><surname>Rothman</surname><given-names>KJ</given-names></name>, <name><surname>Greenland</surname><given-names>S</given-names></name>, <name><surname>Lash</surname><given-names>TL</given-names></name>. <source>Modern Epidemiology</source>. <edition designator="3">3rd</edition> ed. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott William &amp; Wilkins</publisher-name>; <year>2008</year>.</mixed-citation>
    </ref>
    <ref id="pone.0265368.ref043">
      <label>43</label>
      <mixed-citation publication-type="book"><name><surname>VanderWeele</surname><given-names>TJ</given-names></name>. <source>Explanation in Causal Inference: Methods for Mediation and Interaction</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Oxford University Press</publisher-name>; <year>2015</year>.</mixed-citation>
    </ref>
    <ref id="pone.0265368.ref044">
      <label>44</label>
      <mixed-citation publication-type="journal"><name><surname>Hosmer</surname><given-names>DW</given-names></name>, <name><surname>Lemeshow</surname><given-names>S</given-names></name>. <article-title>Confidence Interval Estimation of Interaction</article-title>. <source>Epidemiology</source>. <year>1992</year>;<volume>3</volume>: <fpage>452</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/00001648-199209000-00012</pub-id><?supplied-pmid 1391139?><pub-id pub-id-type="pmid">1391139</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref045">
      <label>45</label>
      <mixed-citation publication-type="journal"><name><surname>Richardson</surname><given-names>DB</given-names></name>, <name><surname>Kaufman</surname><given-names>JS</given-names></name>. <article-title>Estimation of the Relative Excess Risk Due to Interaction and Associated Confidence Bounds</article-title>. <source>Am J Epidemiol</source>. <year>2009</year>;<volume>169</volume>: <fpage>756</fpage>–<lpage>760</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwn411</pub-id><?supplied-pmid 19211620?><pub-id pub-id-type="pmid">19211620</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref046">
      <label>46</label>
      <mixed-citation publication-type="journal"><name><surname>Pang</surname><given-names>M</given-names></name>, <name><surname>Kaufman</surname><given-names>JS</given-names></name>, <name><surname>Platt</surname><given-names>RW</given-names></name>. <article-title>Mixing of confounding and non-collapsibility: a notable deficiency of the odds ratio</article-title>. <source>Am J Cardiol</source>. <year>2013</year>;<volume>111</volume>: <fpage>302</fpage>–<lpage>303</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.amjcard.2012.09.002</pub-id><?supplied-pmid 23290602?><pub-id pub-id-type="pmid">23290602</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref047">
      <label>47</label>
      <mixed-citation publication-type="journal"><name><surname>Funk</surname><given-names>MJ</given-names></name>, <name><surname>Westreich</surname><given-names>D</given-names></name>, <name><surname>Wiesen</surname><given-names>C</given-names></name>, <name><surname>Stürmer</surname><given-names>T</given-names></name>, <name><surname>Brookhart</surname><given-names>MA</given-names></name>, <name><surname>Davidian</surname><given-names>M</given-names></name>. <article-title>Doubly Robust Estimation of Causal Effects</article-title>. <source>Am J Epidemiol</source>. <year>2011</year>;<volume>173</volume>: <fpage>761</fpage>–<lpage>767</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwq439</pub-id><?supplied-pmid 21385832?><pub-id pub-id-type="pmid">21385832</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref048">
      <label>48</label>
      <mixed-citation publication-type="journal"><name><surname>Greenland</surname><given-names>S.</given-names></name><article-title>Interval estimation by simulation as an alternative to and extension of confidence intervals</article-title>. <source>Int J Epidemiol</source>. <year>2004</year>;<volume>33</volume>: <fpage>1389</fpage>–<lpage>1397</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyh276</pub-id><?supplied-pmid 15319402?><pub-id pub-id-type="pmid">15319402</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref049">
      <label>49</label>
      <mixed-citation publication-type="journal"><name><surname>Keil</surname><given-names>Alexander P.</given-names></name>, <name><surname>Buckley</surname><given-names>Jessie P.</given-names></name>, <name><surname>O’Brien</surname><given-names>Katie M.</given-names></name>, <name><surname>Ferguson</surname><given-names>Kelly K.</given-names></name>, <name><surname>Shanshan</surname><given-names>Zhao</given-names></name>, <name><surname>White</surname><given-names>Alexandra J</given-names></name>. <article-title>A Quantile-Based g-Computation Approach to Addressing the Effects of Exposure Mixtures</article-title>. <source>Environmental Health Perspectives</source>. <volume>128</volume>: <fpage>047004</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1289/EHP5838</pub-id><?supplied-pmid 32255670?><pub-id pub-id-type="pmid">32255670</pub-id></mixed-citation>
    </ref>
    <ref id="pone.0265368.ref050">
      <label>50</label>
      <mixed-citation publication-type="journal"><name><surname>Naimi</surname><given-names>AI</given-names></name>, <name><surname>Cole</surname><given-names>SR</given-names></name>, <name><surname>Kennedy</surname><given-names>EH</given-names></name>. <article-title>An introduction to g methods</article-title>. <source>Int J Epidemiol</source>. <year>2017</year>;<volume>46</volume>: <fpage>756</fpage>–<lpage>762</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/ije/dyw323</pub-id><?supplied-pmid 28039382?><pub-id pub-id-type="pmid">28039382</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
